|
1
|
Wallace DC: Mitochondria and cancer. Nat
Rev Cancer. 12:685–698. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
D'Erchia AM, Atlante A, Gadaleta G, Pavesi
G, Chiara M, De Virgilio C, Manzari C, Mastropasqua F, Prazzoli GM,
Picardi E, et al: Tissue-specific mtDNA abundance from exome data
and its correlation with mitochondrial transcription, mass and
respiratory activity. Mitochondrion. 20:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akhmedov AT and Marin-Garcia J:
Mitochondrial DNA maintenance: An appraisal. Mol Cell Biochem.
409:283–305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsu CC, Tseng LM and Lee HC: Role of
mitochondrial dysfunction in cancer progression. Exp Biol Med
(Maywood). 241:1281–1295. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Gisbergen MW, Voets AM, Starmans MH,
de Coo IF, Yadak R, Hoffmann RF, Boutros PC, Smeets HJ, Dubois L
and Lambin P: How do changes in the mtDNA and mitochondrial
dysfunction influence cancer and cancer therapy? Challenges,
opportunities and models. Mutat Res Rev Mutat Res. 764:16–30. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Liu VW, Xue WC, Tsang PC, Cheung
AN and Ngan HY: The increase of mitochondrial DNA content in
endometrial adenocarcinoma cells: A quantitative study using
laser-captured microdissected tissues. Gynecol Oncol. 98:104–110.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin CS, Lee HT, Lee SY, Shen YA, Wang LS,
Chen YJ and Wei YH: High mitochondrial DNA copy number and
bioenergetic function are associated with tumor invasion of
esophageal squamous cell carcinoma cell lines. Int J Mol Sci.
13:11228–11246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu
CW, Chi CW, Tam TN and Wei YH: Mitochondrial genome instability and
mtDNA depletion in human cancers. Ann N Y Acad Sci. 1042:109–122.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai JG, Zhang ZY, Liu QX and Min JX:
Mitochondrial genome microsatellite instability and copy number
alteration in lung carcinomas. Asian Pac J Cancer Prev.
14:2393–2399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin PC, Lin JK, Yang SH, Wang HS, Li AF
and Chang SC: Expression of beta-F1-ATPase and mitochondrial
transcription factor A and the change in mitochondrial DNA content
in colorectal cancer: Clinical data analysis and evidence from an
in vitro study. Int J Colorectal Dis. 23:1223–1232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan AX, Radpour R, Haghighi MM, Kohler C,
Xia P, Hahn S, Holzgreve W and Zhong X: Mitochondrial DNA content
in paired normal and cancerous breast tissue samples from patients
with breast cancer. J Cancer Res Clin Oncol. 135:983–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meierhofer D, Mayr JA, Foetschl U, Berger
A, Fink K, Schmeller N, Hacker GW, Hauser-Kronberger C, Kofler B
and Sperl W: Decrease of mitochondrial DNA content and energy
metabolism in renal cell carcinoma. Carcinogenesis. 25:1005–1010.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hosgood HD III, Liu CS, Rothman N,
Weinstein SJ, Bonner MR, Shen M, Lim U, Virtamo J, Cheng WL,
Albanes D and Lan Q: Mitochondrial DNA copy number and lung cancer
risk in a prospective cohort study. Carcinogenesis. 31:847–849.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu M: Circulating cell-free mitochondrial
DNA as a novel cancer biomarker: Opportunities and challenges.
Mitochondrial DNA. 23:329–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Strelkova I, Abdullaev SA, Snigireva GP,
Bezlepkin VG and Gaziev AI: Share of extracellular mutated
mitochondrial DNA increases in plasma of lung cancer patients
following radiotherapy. Biomed Khim. 56:517–525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shimura T and Kunugita N: Mitochondrial
reactive oxygen species-mediated genomic instability in low-dose
irradiated human cells through nuclear retention of cyclin D1. Cell
Cycle. 15:1410–1414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ellinger J, Muller DC, Muller SC, Hauser
S, Heukamp LC, von Ruecker A, Bastian PJ and Walgenbach-Brunagel G:
Circulating mitochondrial DNA in serum: A universal diagnostic
biomarker for patients with urological malignancies. Urol Oncol.
30:509–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zachariah RR, Schmid S, Buerki N, Radpour
R, Holzgreve W and Zhong X: Levels of circulating cell-free nuclear
and mitochondrial DNA in benign and malignant ovarian tumors.
Obstet Gynecol. 112:843–850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernandes J, Michel V, Camorlinga-Ponce M,
Gomez A, Maldonado C, De Reuse H, Torres J and Touati E:
Circulating mitochondrial DNA level, a noninvasive biomarker for
the early detection of gastric cancer. Cancer Epidemiol Biomarkers
Prev. 23:2430–2438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ellinger J, Albers P, Muller SC, von
Ruecker A and Bastian PJ: Circulating mitochondrial DNA in the
serum of patients with testicular germ cell cancer as a novel
noninvasive diagnostic biomarker. BJU Int. 104:48–52. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kohler C, Radpour R, Barekati Z,
Asadollahi R, Bitzer J, Wight E, Bürki N, Diesch C, Holzgreve W and
Zhong XY: Levels of plasma circulating cell free nuclear and
mitochondrial DNA as potential biomarkers for breast tumors. Mol
Cancer. 8:1052009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu M, Wan YF and Zou QH: Cell-free
circulating mitochondrial DNA in the serum: A potential
non-invasive biomarker for Ewing's sarcoma. Arch Med Res.
43:389–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hou YL, Chen JJ, Wu YF, Xue CJ, Li FZ,
Zheng Q and Chen H: Clinical significance of serum mitochondrial
DNA in lung cancer. Clin Biochem. 46:1474–1477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rusch VW, Asamura H, Watanabe H, Giroux
DJ, Rami-Porta R and Goldstraw P; and Members of IASLC Staging
Committee, : The IASLC lung cancer staging project: A proposal for
a new international lymph node map in the forthcoming seventh
edition of the TNM classification for lung cancer. J Thorac Oncol.
4:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prigerson HG, Bao Y, Shah MA, Paulk ME,
LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson
KB, et al: Chemotherapy use, performance status, and quality of
life at the end of life. JAMA Oncol. 1:778–784. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garassino MC, Cho BC, Kim JH, Mazières J,
Vansteenkiste J, Lena H, Jaime Corral J, Gray JE, Powderly J,
Chouaid C, et al: Durvalumab as third-line or later treatment for
advanced non-small-cell lung cancer (ATLANTIC): An open-label,
single-arm, phase 2 study. Lancet Oncol. 19:521–536. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li L, Hann HW, Wan S, Hann RS, Wang C, Lai
Y, Ye X, Evans A, Myers RE, Ye Z, et al: Cell-free circulating
mitochondrial DNA content and risk of hepatocellular carcinoma in
patients with chronic HBV infection. Sci Rep. 6:239922016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Campbell JD, Alexandrov A, Kim J, Wala J,
Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, et
al: Distinct patterns of somatic genome alterations in lung
adenocarcinomas and squamous cell carcinomas. Nat Genet.
48:607–616. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, He S, Zhu X, Qiao W and Zhang J:
High copy number of mitochondrial DNA predicts poor prognosis in
patients with advanced stage colon cancer. Int J Biol Markers.
31:e382–e388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang G, Qu Y, Dang S, Yang Q, Shi B and
Hou P: Variable copy number of mitochondrial DNA (mtDNA) predicts
worse prognosis in advanced gastric cancer patients. Diagn Pathol.
8:1732013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sabharwal SS and Schumacker PT:
Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles'
heel? Nat Rev Cancer. 14:709–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hofmann JN, Hosgood HD III, Liu CS, Chow
WH, Shuch B, Cheng WL, Lin TT, Moore LE, Lan Q, Rothman N and
Purdue MP: A nested case-control study of leukocyte mitochondrial
DNA copy number and renal cell carcinoma in the prostate, lung,
colorectal and ovarian cancer screening trial. Carcinogenesis.
35:1028–1031. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao S, Yang Y, Liu J, Liu H, Ge N, Yang
H, Zhang H and Xing J: Association of mitochondrial DNA content in
peripheral blood leukocyte with hepatitis B virus-related
hepatocellular carcinoma in a Chinese Han population. Cancer
science. 102:1553–1558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xu E, Sun W, Gu J, Chow WH, Ajani JA and
Wu X: Association of mitochondrial DNA copy number in peripheral
blood leukocytes with risk of esophageal adenocarcinoma.
Carcinogenesis. 34:2521–2524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lynch SM, Weinstein SJ, Virtamo J, Lan Q,
Liu CS, Cheng WL, Rothman N, Albanes D and Stolzenberg-Solomon RZ:
Mitochondrial DNA copy number and pancreatic cancer in the
alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev
Res (Phila). 4:1912–1919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qu F, Liu X, Zhou F, Yang H, Bao G, He X
and Xing J: Association between mitochondrial DNA content in
leukocytes and colorectal cancer risk: A case-control analysis.
Cancer. 117:3148–3155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shen J, Platek M, Mahasneh A, Ambrosone CB
and Zhao H: Mitochondrial copy number and risk of breast cancer: A
pilot study. Mitochondrion. 10:62–68. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
von Kleist-Retzow JC, Hornig-Do HT,
Schauen M, Eckertz S, Dinh TA, Stassen F, Lottmann N, Bust M,
Galunska B, Wielckens K, et al: Impaired mitochondrial Ca2+
homeostasis in respiratory chain-deficient cells but efficient
compensation of energetic disadvantage by enhanced anaerobic
glycolysis due to low ATP steady state levels. Exp Cell Res.
313:3076–3089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee HC, Hsu LS, Yin PH, Lee LM and Chi CW:
Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp
deletion in human cancer cells during mitochondrial DNA depletion.
Mitochondrion. 7:157–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Grunnet M and Sorensen JB:
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung
Cancer. 76:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhou W, Zhu M, Gui M, Huang L, Long Z,
Wang L, Chen H, Yin Y, Jiang X, Dai Y, et al: Peripheral blood
mitochondrial DNA copy number is associated with prostate cancer
risk and tumor burden. PLoS One. 9:e1094702014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lissoni P, Brivio F, Fumagalli L, Messina
G, Ghezzi V, Frontini L, Giani L, Vaghi M, Ardizzoia A and Gardani
GS: Efficacy of cancer chemotherapy in relation to the pretreatment
number of lymphocytes in patients with metastatic solid tumors. Int
J Biol Markers. 19:135–140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Weerts MJ, Sieuwerts AM, Smid M, Look MP,
Foekens JA, Sleijfer S and Martens JW: Mitochondrial DNA content in
breast cancer: Impact on in vitro and in vivo phenotype and patient
prognosis. Oncotarget. 7:29166–29176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tu H, Gu J, Meng QH, Kim J, Davis JW, He
Y, Wagar EA, Thompson TC, Logothetis CJ and Wu X: Mitochondrial DNA
copy number in peripheral blood leukocytes and the aggressiveness
of localized prostate cancer. Oncotarget. 6:41988–41996. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lin CS, Wang LS, Tsai CM and Wei YH: Low
copy number and low oxidative damage of mitochondrial DNA are
associated with tumor progression in lung cancer tissues after
neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg.
7:954–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fachal L, Mosquera-Miguel A, Gomez-Caamano
A, Sánchez-García M, Calvo P, Lobato-Busto R, Salas A and Vega A:
Evaluating the role of mitochondrial DNA variation to the genetic
predisposition to radiation-induced toxicity. Radiother Oncol.
111:199–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yeung M, Hurren R, Nemr C, Wang X,
Hershenfeld S, Gronda M, Liyanage S, Wu Y, Augustine J, Lee EA, et
al: Mitochondrial DNA damage by bleomycin induces AML cell death.
Apoptosis. 20:811–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dang S, Qu Y, Wei J, Shao Y, Yang Q, Ji M,
Shi B and Hou P: Low copy number of mitochondrial DNA (mtDNA)
predicts worse prognosis in early-stage laryngeal cancer patients.
Diagn Pathol. 9:282014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cook CC, Kim A, Terao S, Gotoh A and
Higuchi M: Consumption of oxygen: A mitochondrial-generated
progression signal of advanced cancer. Cell death Dis. 3:e2582012.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Vermulst M, Bielas JH and Loeb LA:
Quantification of random mutations in the mitochondrial genome.
Methods. 46:263–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lin CS, Lee HT, Lee MH, Pan SC, Ke CY,
Chiu AW and Wei YH: Role of mitochondrial DNA copy number
alteration in human renal cell carcinoma. Int J Mol Sci. 17:2016.
View Article : Google Scholar
|
|
58
|
Guha M, Srinivasan S, Ruthel G, Kashina
AK, Carstens RP, Mendoza A, Khanna C, Van Winkle T and Avadhani NG:
Mitochondrial retrograde signaling induces epithelial-mesenchymal
transition and generates breast cancer stem cells. Oncogene.
33:5238–5250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Naito A, Cook CC, Mizumachi T, Wang M, Xie
CH, Evans TT, Kelly T and Higuchi M: Progressive tumor features
accompany epithelial-mesenchymal transition induced in
mitochondrial DNA-depleted cells. Cancer Sci. 99:1584–1588. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Adib-Conquy M and Cavaillon JM:
Compensatory anti-inflammatory response syndrome. Thromb Haemost.
101:36–47. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Moro L, Arbini AA, Yao JL, di San t'Agnese
PA, Marra E and Greco M: Mitochondrial DNA depletion in prostate
epithelial cells promotes anoikis resistance and invasion through
activation of PI3K/Akt2. Cell Death Differ. 16:571–583. 2009.
View Article : Google Scholar : PubMed/NCBI
|
